SFJ Pharmaceuticals, Inc.   Report issue

Contributed to NME For profit Phase 1 Phase 3
Founded: Pleasanton CA United States (2008)

Organization Overview

First Clinical Trial
2012
NCT01599754
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

SFJ Pharmaceuticals, Inc.